Furthermore, Qazi et al. reported that recurrent GBM (rGBM) have increased expression of both EphA2 and EphA3 and demonstrated that their coexpression is linked to strong tumorigenicity in vitro and in vivo. The gene discussed is EPHA2; the disease is glioblastoma.